抗凝药在射频消融房颤后预防肺栓塞的应用进展

Application of anticoagulant in the prevention of pulmonary embolism after radiofrequency ablation of atrial fibrillation

射频消融已在心房颤动(简称房颤)、阵发性室上性心动过速及某些室性心律失常的治疗上得到广泛应用,肺栓塞是射频消融术后严重和潜在致命的并发症。抗凝治疗对于肺栓塞非常重要,目前各种各样的新型抗凝药物不断出现,现就新型口服抗凝药物和低分子肝素在射频消融术房颤后预防肺栓塞的应用进展做一综述。

Radiofrequency ablation has been widely used in the treatment of paroxysmal supraventricular tachycardia, atrial fibrillation and certain ventricular arrhythmias. Pulmonary embolism is a serious and potentially fatal complication of radiofrequency ablation. Anticoagulants are important for the treatment of pulmonary embolism. In recent years, a variety of new anticoagulant drugs are emerging. The new oral anticoagulant and low molecular weight heparin are applied to prevention of pulmonary embolism after radiofrequency ablation , doing a review of the progress.